Man Group PLC Standard Biotools Inc. Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $491,190 - $869,257	-297,691 Reduced 95.84%	12,913 $22,000
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $210,232 - $312,538	112,424 Added 56.73%	310,604 $841,000
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $315,106 - $541,031	198,180 New	198,180 $437,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $59,079 - $83,556	-21,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $129,954 - $219,454	-35,800 Reduced 62.92%	21,100 $83,000
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $312,950 - $421,629	56,900 New	56,900 $375,000
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $152,759 - $188,390	-13,295 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $112,608 - $190,916	13,295 New	13,295 $177,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $118M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.